Skip to main content
Premium Trial:

Request an Annual Quote

Codex DNA: Synthetic SARS-CoV-2 B.1.617

Codex DNA has released a full-length synthetic genome for the SARS-CoV-2 Delta variant (B.1.617), constructed and manufactured using the firm's BioXp 3250 synthetic biology benchtop system. The genome can be used by researchers to develop therapies, vaccines, and diagnostics to slow the spread of the variant. Overall, Codex currently offers 13 different SARS-CoV-2 synthetic genomes.